The number 1667 is the max they will enroll as per the study saying "The study plans to enrol upto 1,667 patients". So as long as they have enough of all the categories to be significant they can stop enrolling at any time now .
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides SMARTCOUGH-C-2 Study Update
Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-23
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)